Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.

about

The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.

P2860

Q47547621-8E8EF45C-F3DD-4EF9-B3B9-AD0FDC9ECA74

P2860

Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.

Item

http://www.wikidata.org/entity/Q38962952

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Using three-dimensional echoca ...... : does it make any difference.

@en

type

Item

label

Using three-dimensional echoca ...... : does it make any difference.

@en

prefLabel

Using three-dimensional echoca ...... : does it make any difference.

@en

P1476

Using three-dimensional echoca ...... : does it make any difference.

@en

P2093

Haitham A Badran

http://www.w3.org/2001/XMLSchema#string

John Z Kamel

http://www.w3.org/2001/XMLSchema#string

Mohamed A Abdelhamid

http://www.w3.org/2001/XMLSchema#string

Tarek R Mohamed

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical utility of speckle-tracking echocardiography in cardiac resynchronisation therapy

Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Left ventricular ejection fraction and volumes: it depends on the imaging method.

Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications.

The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cardiac resynchronization in chronic heart failure.

Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome.

Measurement of left ventricular dyssynchrony in patients with ischaemic cardiomyopathy: a comparison of real-time three-dimensional and tissue Doppler echocardiography.

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.

P2888

s10840-017-0229-7

P304

299-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10840-017-0229-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28194611

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.

about

P2860

P2860

Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921